Resident Research Presentations

The following presentations will be given by our residents at the 2017 American Society for Radiation Oncology (ASTRO) annual meeting. Many of our residents have received grants and awards for their work.

Leo Luo
Association of delayed adjuvant therapy and overall survival in early stage endometrial cancer

Leo Luo
Outcome and late toxicity of breast cancer patients treated with post-mastectomy proton therapy

Brandon Imber
Prognostic Impact of Tumor Location and Lymph Node (LN) Burden for Patients with Stage IIIA Non-small Cell Lung Cancer (NSCLC) Receiving Post-operative Radiotherapy (PORT)

Brandon Imber
Lesion Response and Intracranial Control of Brain Metastases from Non Small Cell Lung Cancer (NSCLC) After Stereotactic Radiosurgery or Hypofractionated Radiation Therapy Combined with Checkpoint Inhibitors

Emily Weg
Assessing Outcomes in the Management of Post-Mastectomy Local-Regional Recurrences (LRR) in Breast Cancer

Emily Weg
Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15 Year Outcomes Data

Thomas Beckham
Intensity Modulated radiation therapy with or without concurrent chemotherapy in non-Anaplastic Thyroid Cancer with Unresectable or Gross Residual Disease Presentation

Kenneth Pitter
Endoluminal High-Dose Rate Brachytherapy for Medically Inoperable Early Stage and Locally Recurrent Esophageal cancer: Implementation of a Novel Applicator and Updated Institutional Experience

Kenneth Pitter
FDG-PET Maximum Standardized Uptake Value and Histological Subtype Predict High Risk for Recurrence in Early-Stage Lung Adenocarcinoma Treated with Stereotactic Body Radiation Therapy

Dana Casey
Local Control with Reduced-Dose Radiation Therapy for High-Risk Neuroblastoma: Results from a Prospective Trial

Dana Casey
Dose-Escalation is Needed for Gross Disease in High-Risk Neuroblastoma

Dana Casey
Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control be Achieved?

Dana Casey
Long-term Survival after Stereotactic and Hypofractionated Radiation Therapy in Patients with Metastatic Melanoma Brain Metastases

Robert Samstein
Partial Tumor Irradiation in a Murine Model is Sufficient for Tumor Control via Activation of an Anti-tumor Immune Response

Robert Samstein
Combined immune checkpoint blockade and radiotherapy: Timing and dose fractionation associated with greatest survival duration among over 750 treated patients

Suchit Patel
Outcomes of p16-positive EBV-negative Nasopharyngeal Carcinoma Treated with Definitive Chemoradiation at a Large North American Cancer Center

Suchit Patel
Proton Quad Shot RT for Palliation in Patients with Advanced Sarcoma

Aaron Wild
Improved Survival and Intracranial Control Associated with Radiation Necrosis After Ipilimumab and Stereotactic Radiosurgery for Melanoma Brain Metastases

Aaron Wild
FDG-PET Maximum Standardized Uptake Value is Prognostic for Survival and Disease-Free Survival in Stage IIIA-N2 Non-Small Cell Lung Cancer Patients Who Receive Postoperative Radiation Therapy

Samuel Bakhoum
Radiation-induced activation of innate immune pathways from errors in mitosis

Joanna Yang
Palliative Radiation for Bone Metastases: Reconsidering the Optimal Timing

Joanna Yang
HEART (Heart Evaluation After RT): Novel Detection of Cardiotoxicity in Breast Cancer Patients

Natalie Lockney
PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT)

Jonathan Leeman
Tumor spread through airspaces and histologic subtype predict outcomes following post-operative radiotherapy for locally advanced lung adenocarcinoma

Jonathan Leeman
Upregulation of alternative end joining in HPV+ head and neck cancer

Jonathan Leeman
Long-term survival in oligometastatic head and neck cancer

Neil Taunk
Early Post-treatment Assessment of MRI Perfusion Biomarkers Can Predict Long-term Response of NSCLC Brain Metastases to SRS: a Longitudinal Analysis

Samuel Bakhoum
Department of Defense (DoD) Breast Cancer Breakthrough Award, 3 year-grant, 2016-2019
Elsa U. Pardee Foundation Grant, 2016-2017

Jonathan Leeman
American Society of Clinical Oncology (ASCO) Conquer Cancer Merit Award, 2016

Natalie Lockney
American College of Radiation Oncology (ACRO) Resident Seed Grant, 2015

Benjamin Lok
Lung Cancer Research Foundation (LCRF) Grant, 2 year-grant, 2016-2018
American Association for Cancer Research (AACR) Takeda Scholar-in-Training Award, 2016
Conquer Cancer Foundation of American Society of Clinical Oncology (ASCO) Young Investigator Award, 2016
Radiological Society of North America (RSNA) Resident Research Grant, 2016

Neil Taunk
IMRAS (Imaging and Radiation Sciences) Seed Grant, 2016